Modeling biological rhythms in failure time data

Background The human body exhibits a variety of biological rhythms. There are patterns that correspond, among others, to the daily wake/sleep cycle, a yearly seasonal cycle and, in women, the menstrual cycle. Sine/cosine functions are often used to model biological patterns for continuous data, but this model is not appropriate for analysis of biological rhythms in failure time data. Methods We adapt the cosinor method to the proportional hazards model and present a method to provide an estimate and confidence interval of the time when the minimum hazard is achieved. We then apply this model to data taken from a clinical trial of adjuvant of pre-menopausal breast cancer patients. Results The application of this technique to the breast cancer data revealed that the optimal day for pre-resection incisional or excisional biopsy of 28-day cycle (i. e. the day associated with the lowest recurrence rate) is day 8 with 95% confidence interval of 4–12 days. We found that older age, fewer positive nodes, smaller tumor size, and experimental treatment were predictive of longer relapse-free survival. Conclusion In this paper we have described a method for modeling failure time data with an underlying biological rhythm. The advantage of adapting a cosinor model to proportional hazards model is its ability to model right censored data. We have presented a method to provide an estimate and confidence interval of the day in the menstrual cycle where the minimum hazard is achieved. This method is not limited to breast cancer data, and may be applied to any biological rhythms linked to right censored data.

[1]  Tong Yl,et al.  Parameter estimation in studying circadian rhythms. , 1976 .

[2]  F. Lévi,et al.  Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. , 1990, Journal of the National Cancer Institute.

[3]  F. Lévi,et al.  Circadian chronotherapy for human cancers. , 2001, The Lancet. Oncology.

[4]  Circadian rhythm analysis when output is collected at intervals. , 1977, Biometrics.

[5]  F. Lévi,et al.  A phase I trial of 21-day continuous venous infusion of alpha-interferon at circadian rhythm modulated rate in cancer patients. , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[6]  I. Fentiman,et al.  Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer , 1991, The Lancet.

[7]  J. Spratt,et al.  Breast cancer detection demonstration project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle , 1993, Journal of surgical oncology.

[8]  R. Fisher.  The Advanced Theory of Statistics , 1943, Nature.

[9]  D.,et al.  Regression Models and Life-Tables , 2022 .

[10]  M. B. Brown,et al.  A flexible model for human circadian rhythms. , 1996, Biometrics.

[11]  Y L Tong,et al.  Parameter estimation in studying circadian rhythms. , 1976, Biometrics.

[12]  D. S. Hickey,et al.  Analysis of circadian rhythms by fitting a least squares sine curve. , 1984, Computers in biology and medicine.

[13]  R. Demicheli,et al.  Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour , 2004, Breast Cancer Research.

[14]  Mary Schneider,et al.  Variability in the phases of the menstrual cycle. , 2006, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[15]  S. Tsutsui,et al.  Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer. , 1999, European journal of cancer.

[16]  A. Reinberg,et al.  Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  W. Hrushesky.  Rhythmic menstrual cycle modulation of breast cancer biology , 2000, Journal of surgical oncology.

[18]  W. Hrushesky,et al.  Circadian rhythms and cancer chemotherapy. , 1996, Critical reviews in eukaryotic gene expression.

[19]  J. Forbes,et al.  Timing breast cancer surgery , 1991, The Lancet.

[20]  E. Van Cutsem,et al.  Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). , 1999, European journal of cancer.

[21]  N. L. Johnson,et al.  The Advanced Theory of Statistics: Volume I (1958): Distribution Theory , 1962 .

[22]  Bradley Efron,et al.  Computer-Intensive Methods in Statistical Regression , 1988 .

[23]  M. Milella,et al.  Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women , 1999, Breast Cancer Research and Treatment.

[24]  R. Senie,et al.  Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. , 1991, Annals of internal medicine.

[25]  A. Luini,et al.  Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments. , 2001, Critical reviews in oncology/hematology.

[26]  Franz Halberg,et al.  Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. , 2003, Journal of experimental therapeutics & oncology.

[27]  F Halberg,et al.  Methods for cosinor-rhythmometry. , 1979, Chronobiologia.

[28]  Yuedong Wang,et al.  Shape‐Invariant Modeling of Circadian Rhythms with Random Effects and Smoothing Spline ANOVA Decompositions , 2003, Biometrics.

[29]  Ontario,et al.  Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer , 1994, The British journal of surgery.

[30]  D. Tu,et al.  Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. J. Jacobson,et al.  Acoustical effects of ocean current shear structures in the parabolic approximation , 1987 .

[32]  R. Tibshirani,et al.  Local Likelihood Estimation , 1987 .

[33]  S. Gruber,et al.  MENSTRUAL INFLUENCE ON SURGICAL CURE OF BREAST CANCER , 1989, The Lancet.

[34]  Patricia Wood,et al.  Circadian Timing in Cancer Treatment: The Biological Foundation for an Integrative Approach , 2003, Integrative cancer therapies.